Annual D&A
$42.39M$494.00K-1.15%
Summary
- Current Value
- As of today, GH annual D&A is $42.39M, down -1.15% on
- Historical Performance
- GH annual D&A is up +90.32% over the past 3 years, and up +271.46% over the past 5 years
- All-Time High Comparison
- GH annual D&A is currently -1.15% below its historical high of $42.88M set on
- 3-Year Low Comparison
- GH annual D&A is +17.87% above its 3-year low of $35.96M reached on an earlier date
- Sector Comparison
- GH annual D&A is higher than 83.59% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $42.39M | -1.1% | +90.3% | +271.5% | +1047.8% | |
| Quarterly D&A | $9.41M | -11.2% | -4.1% | +872.9% | – | |
| TTM D&A | $40.14M | -6.2% | +25.9% | +134.6% | – | |
| Price | $110.17 | +201.1% | +296.4% | -22.9% | – | |
| Annual SG&A | $545.06M | +20.9% | +36.8% | +290.1% | +1409.3% | |
| Annual Total Expenses | $1.18B | +4.8% | +50.7% | +298.5% | +1611.5% | |
| Annual Operating Expenses | $892.81M | -1.0% | +34.9% | +295.0% | +1800.7% | |
| Annual Revenue | $739.02M | +31.0% | +97.8% | +244.7% | +2826.9% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $42.88M | -1.1% | |
| 5Y | $42.88M | -1.1% | |
| All | $42.88M | -1.1% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $35.96M | N/A | +17.9% |
| 5Y | $16.07M | N/A | +163.8% |
| All | $3.69M | +1047.8% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $42.39M | -1.2% | |
| $42.88M | +19.2% | |
| $35.96M | +61.5% | |
| $22.27M | +38.6% | |
| $16.07M | +40.8% |
| Year | Value | Change |
|---|---|---|
| $11.41M | +59.9% | |
| $7.14M | +37.1% | |
| $5.21M | +41.0% | |
| $3.69M | - |
FAQ
What is the current annual D&A of GH?
As of today, GH annual D&A is $42.39M
What is 1-year change in GH annual D&A?
GH annual D&A is down -1.15% year-over-year
What is 3-year change in GH annual D&A?
GH annual D&A is up +90.32% over the past 3 years
How far is GH annual D&A from its all-time high?
GH annual D&A is currently -1.15% below its historical high of $42.88M set on December 31, 2023
How does GH annual D&A rank versus sector peers?
GH annual D&A is higher than 83.59% of companies in Healthcare sector
When is GH next annual earnings release?
The next annual earnings release for GH is on
Quarterly D&A
$9.41M$634.00K-6.31%
Summary
- Current Value
- As of today, GH quarterly D&A is $9.41M, down -6.31% on
- Historical Performance
- GH quarterly D&A is down -11.23% year-over-year, and down -4.07% over the past 3 years
- All-Time High Comparison
- GH quarterly D&A is currently -14.76% below its historical high of $11.04M set on
- 3-Year Low Comparison
- GH quarterly D&A is at its 3-year low
- Sector Comparison
- GH quarterly D&A is higher than 81.38% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $9.41M | -6.3% | -11.2% | -4.1% | +872.9% | |
| Annual D&A | $42.39M | – | -1.1% | +90.3% | +271.5% | |
| TTM D&A | $40.14M | -2.9% | -6.2% | +25.9% | +134.6% | |
| Price | $110.17 | +68.8% | +201.1% | +296.4% | -22.9% | |
| Quarterly SG&A | $180.64M | +6.4% | +22.9% | +48.7% | +97.7% | |
| Quarterly Total Expenses | $357.92M | +7.8% | +19.6% | +28.1% | +135.1% | |
| Quarterly Operating Expenses | $270.60M | +5.2% | +15.5% | +22.4% | +112.0% | |
| Quarterly Revenue | $265.20M | +14.3% | +38.5% | +125.9% | +255.6% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $10.45M | N/A | -10.0% |
| 3Y | $11.04M | -14.8% | |
| 5Y | $11.04M | -14.8% | |
| All | $11.04M | -14.8% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $9.41M | at low | |
| 3Y | $9.41M | at low | |
| 5Y | $4.60M | N/A | +104.4% |
| All | $967.00K | +872.9% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of GH?
As of today, GH quarterly D&A is $9.41M
What is GH quarterly D&A most recent change?
GH quarterly D&A was down -6.31% on September 30, 2025
What is 1-year change in GH quarterly D&A?
GH quarterly D&A is down -11.23% year-over-year
How far is GH quarterly D&A from its all-time high?
GH quarterly D&A is currently -14.76% below its historical high of $11.04M set on September 30, 2023
How does GH quarterly D&A rank versus sector peers?
GH quarterly D&A is higher than 81.38% of companies in Healthcare sector
When is GH next earnings release?
The next earnings release for GH is on
TTM D&A
$40.14M$1.19M-2.88%
Summary
- Current Value
- As of today, GH TTM D&A is $40.14M, down -2.88% on
- Historical Performance
- GH TTM D&A is down -6.22% year-over-year, and up +25.90% over the past 3 years
- All-Time High Comparison
- GH TTM D&A is currently -7.19% below its historical high of $43.25M set on
- 3-Year Low Comparison
- GH TTM D&A is +11.62% above its 3-year low of $35.96M reached on an earlier date
- Sector Comparison
- GH TTM D&A is higher than 82.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $40.14M | -2.9% | -6.2% | +25.9% | +134.6% | |
| Annual D&A | $42.39M | – | -1.1% | +90.3% | +271.5% | |
| Quarterly D&A | $9.41M | -6.3% | -11.2% | -4.1% | +872.9% | |
| Price | $110.17 | +68.8% | +201.1% | +296.4% | -22.9% | |
| TTM SG&A | -$10.89B | -1843.2% | -2255.7% | -2551.0% | -4644.8% | |
| TTM Revenue | $902.57M | +8.9% | +30.4% | +109.5% | +232.7% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $42.39M | N/A | -5.3% |
| 3Y | $43.25M | -7.2% | |
| 5Y | $43.25M | -7.2% | |
| All | $43.25M | -7.2% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $40.14M | at low | |
| 3Y | $35.96M | N/A | +11.6% |
| 5Y | $16.07M | N/A | +149.9% |
| All | $1.40M | +2777.4% |
TTM D&A History
FAQ
What is the current TTM D&A of GH?
As of today, GH TTM D&A is $40.14M
What is GH TTM D&A most recent change?
GH TTM D&A was down -2.88% on September 30, 2025
What is 1-year change in GH TTM D&A?
GH TTM D&A is down -6.22% year-over-year
How far is GH TTM D&A from its all-time high?
GH TTM D&A is currently -7.19% below its historical high of $43.25M set on March 31, 2024
How does GH TTM D&A rank versus sector peers?
GH TTM D&A is higher than 82.07% of companies in Healthcare sector
When is GH next earnings release?
The next earnings release for GH is on
Data Sources & References
- GH Official Website guardanthealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1576280/000157628025000277/0001576280-25-000277-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1576280/000157628025000044/0001576280-25-000044-index.htm
- GH Profile on Yahoo Finance finance.yahoo.com/quote/GH
- GH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gh